Vergoeding 2019-2023 voor ATC-subgroep N02CC : Selectieve serotonine-agonisten
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N02CC01 Sumatriptan (Imigran ®) | 12.669.200 | 12.134.800 | 13.514.900 | 15.265.300 | 16.277.700 |
| N02CC02 Naratriptan (Naramig ®) | 164.620 | 149.020 | 133.330 | 140.760 | 139.670 |
| N02CC03 Zolmitriptan (Zomig zip ®) | 426.850 | 372.500 | 279.130 | 345.880 | 413.080 |
| N02CC04 Rizatriptan (Maxalt ®) | 1.558.000 | 1.581.500 | 1.252.600 | 1.545.400 | 1.907.200 |
| N02CC05 Almotriptan (Almogran ®) | 388.760 | 325.650 | 309.470 | 326.760 | 345.510 |
| N02CC06 Eletriptan (Relpax ®) | 1.885.600 | 1.629.700 | 1.579.400 | 1.795.100 | 1.944.900 |
| N02CC07 Frovatriptan (Fromirex ®) | 893.520 | 745.560 | 721.010 | 872.080 | 851.230 |
| N02CC08 Lasmiditan (Rayvow ®) | . | . | . | . | 31.814 |
| Totaal | 17.986.550 | 16.938.730 | 17.789.840 | 20.291.280 | 21.911.104 |